Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee backs bill requiring opioid risk discussions with patients; Health and AG offer amendments
Summary
The Senate health committee on April 22 recommended bill 36‑0021 — which would require practitioners to discuss opioid necessity, non‑opioid alternatives and overdose risks before an initial and before a third schedule‑II opioid prescription — and voted 6–0 (with one absence) to forward the bill for further drafting.
The Senate Committee on Health, Hospitals and Human Services voted April 22 to give a favorable recommendation to bill 36‑0021, a measure that would require practitioners to discuss specific risks and alternatives with patients when prescribing opioids.
The bill, introduced by Senator Marvin A. Bridal, would require clinicians to discuss the prescription’s necessity, non‑opioid alternatives, and the risks of opioid use — including addiction, dependence and fatal respiratory depression when opioids are misused or combined with other depressants — before an initial schedule‑II opioid prescription and again before a third prescription during a course of treatment. Practitioners would document that the discussion took place in…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
